dr. zandberg on the role of durvalumab in head and neck cancer
Published 6 years ago • 143 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:03
dr. zandberg on durvalumab trial in head and neck cancer
-
0:54
dr. zandberg on the role of immunotherapy in head and neck cancer
-
0:44
dr. zandberg on biomarker development in head and neck cancer
-
1:08
dr. zandburg on biomarker development in head and neck cancer
-
1:42
dr. feldman on the future of durvalumab and tremilimumab in nsclc
-
6:06
stage iii nsclc: when to start durvalumab
-
3:55
durvalumab in novel combinations for head and neck cancer
-
3:31
expert comment: caspian trial of durvalumab in sclc | raffaele califano
-
1:00
trial of durvalumab for bladder cancer
-
6:37
caspian trial: durvalumab and chemotherapy in es-sclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
1:35
dr. fakih on durvalumab and tremelimumab in crc
-
3:02
danube: pd-l1 as a predictor of survival in patients with muc
-
3:48
poseidon: durvalumab /- tremelimumab chemo in 1l mnsclc
-
2:49
first-in-human trial of medi1191 plus durvalumab in patients with advanced solid tumors
-
2:10
dr. langer on the benefit of durvalumab in stage iii nsclc
-
1:24
durvalumab: the new standard of care for nsclc?
-
3:07
the use of durvalumab in locally advanced nsclc